Neurontin Studies Cooked the Books

by GoozNews ~ 11 Nov 2009 06:44pm

Kay Dickerson, an epidemiologist at Johns Hopkins University, has a new study in the New England Journal of Medicine comparing the outcomes of a dozen studies of Neurontin (gabapentin) to their original protocols. It turns out the researchers working on the Pfizer/Parke-Davis anticonvulsant drug changed the endpoints in eight of those trials while they were underway, she reports. MedPage Today has a good recap of her study here.

Comments

Thanks Merrill I've been

Thanks Merrill


I've been writting on cancer discussion boards on the internet that anecdotally, drugs like Neurontin are used off-label. Most drugs are prescribed off-label. One must be cautious that off-label remedies are fully discussed with patients and must not do any harm. A number of practioners like to use Neurontin (gabapentin) for all neuropathy. It is already used for diabetic neuropathy and neuropathic pain and (after a work-up and ruling out other causes) they found this to work. But again, do no harm.